• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Indian J Med Res . Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India

tetano

Editor, Senior Moderator
Indian J Med Res


. 2020 Jul 22.
doi: 10.4103/ijmr.IJMR_1788_20. Online ahead of print.
Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India


Anant Mohan[SUP] 1 [/SUP], Pawan Tiwari[SUP] 1 [/SUP], Sushma Bhatnagar[SUP] 2 [/SUP], Ankit Patel[SUP] 1 [/SUP], Abhishek Maurya[SUP] 1 [/SUP], Lalit Dar[SUP] 3 [/SUP], Sourabh Pahuja[SUP] 1 [/SUP], Rakesh Garg[SUP] 2 [/SUP], Nishkarsh Gupta[SUP] 2 [/SUP], Biswajeet Sahoo[SUP] 4 [/SUP], Ritu Gupta[SUP] 5 [/SUP], Ved Prakash Meena[SUP] 6 [/SUP], Saurabh Vig[SUP] 2 [/SUP], Anuja Pandit[SUP] 2 [/SUP], Saurabh Mittal[SUP] 1 [/SUP], Karan Madan[SUP] 1 [/SUP], Vijay Hadda[SUP] 1 [/SUP], Tanima Dwivedi[SUP] 4 [/SUP], Aashish Choudhary[SUP] 3 [/SUP], Megha Brijwal[SUP] 3 [/SUP], Manish Soneja[SUP] 6 [/SUP], Randeep Guleria[SUP] 7 [/SUP], Brajesh Ratre[SUP] 2 [/SUP], Balbir Kumar[SUP] 2 [/SUP], Shweta Bhopale[SUP] 2 [/SUP], Smriti Panda[SUP] 8 [/SUP], Angel Rajan Singh[SUP] 9 [/SUP], Sheetal Singh[SUP] 5 [/SUP], Laxmitej Wundavalli[SUP] 5 [/SUP]



Affiliations

Abstract

Background & objectives: : In December 2019, a novel coronavirus (SARS-CoV-2) emerged in China and rapidly spread globally including India. The characteristic clinical observations and outcomes of this disease (COVID-19) have been reported from different countries. The present study was aimed to describe the clinico-demographic characteristics and in-hospital outcomes of a group of COVID-19 patients in north India.
Methods: : This was a prospective, single-centre collection of data regarding epidemiological, demographic, clinical and laboratory parameters, management and outcome of COVID-19 patients admitted in a tertiary care facility in north India. Patient outcomes were recorded as death, discharge and still admitted.
Results: : Data of 144 patients with COVID-19 were recorded and analyzed. The mean age of the patients was 40.1΁13.1 yr, with 93.1 per cent males, and included 10 (6.9%) foreign nationals. Domestic travel to or from affected States (77.1%) and close contact with COVID-19 patients in congregations (82.6%) constituted the most commonly documented exposure. Nine (6.3%) patients were smokers, with a median smoking index of 200. Comorbidities were present in 23 (15.9%) patients, of which diabetes mellitus (n=16; 11.1%) was the most common. A significant proportion of patients had no symptoms (n=64; 44.4%); among the symptomatic, cough (34.7%) was the most common symptom followed by fever (17.4%) and nasal symptoms (2.15%). Majority of the patients were managed with supportive treatment with hydroxychloroquine and azithromycin given on a case-to-case basis. Only five (3.5%) patients required oxygen supplementation, four (2.8%) patients had severe disease requiring intensive care, one required mechanical ventilation and mortality occurred in two (1.4%) patients. The time to reverse transcription-polymerase chain reaction (RT-PCR) negativity was 16-18 days.
Interpretation & conclusions: : In this single-centre study of 144 hospitalized patients with confirmed COVID-19 in north India, the characteristic findings included younger age, high proportion of asymptomatic patients, long time to PCR negativity and low need for intensive care unit care.

Keywords: Clinico-epidemiologic - cough - COVID-19 - north India - outcome - prospective.
 
Back
Top Bottom